LIRAPYN

This brand name is authorized in Nigeria.

Active ingredients

The drug LIRAPYN contains one active pharmaceutical ingredient (API):

1	Pregabalin UNII 55JG375S6M - PREGABALIN
	Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system.
	Read more about Pregabalin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4772	Capsule	Lirapyn Capsules 50 mg CAP 50 mg		07/05/2021
B4-8165	Capsule	Lirapyn Capsules 75mg CAP 75 mg 47packs	Lirapyn Capsules 75mg PREGABALIN CAPSULES 75MG Pregabalin 75mg, Mannitol, Talc B4-8165 Drugs Imported Products 47packs POM 2 18/05/2022 RANBAXY NIGERIA LIMITED, ABIMBOLA STREET, ILASAMAJA, ISOLO LAGOS LAGOS 17932744 rosanna.iwuala@sunpharma.com SUN PHARMACEUTICAL LTD (INDIA), Village Ganguwala, Paonta Sahib, Himachal Pradesh – 173025, India , India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BF02	Pregabalin	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BF Gabapentinoids
Discover more medicines within N02BF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4772, B4-8165